Cargando…

2012 ESC STEMI guidelines and reperfusion therapy: Evidence base ignored, threatening optimal patient management

Detalles Bibliográficos
Autores principales:	Terkelsen, Christian Juhl, Pinto, Duane S, Thiele, Holger, Clemmensen, Peter, Nikus, Kjell, Lassen, Jens Flensted, Hildick-Smith, David, Christiansen, Evald Høj, Aarøe, Jens, Hansen, Hans-Henrik Tilsted, Stankovic, Goran, Junker, Anders, Sianos, Georgios, Olivecrona, Göran, Bøtker, Hans Erik, Gibson, Charles Michael, Boersma, Eric
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BMJ Publishing Group 2013
Materias:	Point-Counterpoint
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3717760/ https://www.ncbi.nlm.nih.gov/pubmed/23781110 http://dx.doi.org/10.1136/heartjnl-2013-304117

Ejemplares similares

Event detection using population-based health care databases in randomized clinical trials: a novel research tool in interventional cardiology
por: Thuesen, Leif, et al.
Publicado: (2013)

Comparison of zotarolimus-eluting and sirolimus-eluting coronary stents: a study from the Western Denmark Heart Registry
por: Maeng, Michael, et al.
Publicado: (2012)

Counterpoint: Flexibilization of Fasting for Laboratory Determination of the Lipid Profile in Brazil: Science or Convenience?
por: Izar, Maria Cristina de Oliveira
Publicado: (2018)

Research methods in international business: The challenge of complexity
por: Eden, Lorraine, et al.
Publicado: (2020)

Why the world economy needs, but will not get, more globalization in the post-COVID-19 decade
por: Ciravegna, Luciano, et al.
Publicado: (2021)

Not all patients with AML over 60 years of age should be offered early allogeneic stem cell transplantation
por: Deeg, H. Joachim
Publicado: (2022)

Family-owned multinational enterprises in the post-pandemic global economy
por: Calabrò, Andrea, et al.
Publicado: (2022)

Is BTKi or BCL2i preferable as first novel therapy in patients with CLL? The case for BCL2i
por: Seymour, John F.
Publicado: (2022)

What merits greater scholarly attention in international business?
por: Grøgaard, Birgitte, et al.
Publicado: (2022)

Capitalizing on the uniqueness of international business: Towards a theory of place, space, and organization
por: Beugelsdijk, Sjoerd
Publicado: (2022)

International business and Africa: Theoretical and applied challenges, and future directions
por: Kamoche, Ken, et al.
Publicado: (2023)

Clinical outcomes after treatment of multiple lesions with zotarolimus-eluting versus sirolimus-eluting coronary stents (a SORT OUT III substudy)
por: Thim, Troels, et al.
Publicado: (2012)

ST Elevation Infarction after Heart Transplantation Induced by Coronary Spasms and Mural Thrombus Detected by Optical Coherence Tomography
por: Clemmensen, Tor Skibsted, et al.
Publicado: (2016)

Earlier reperfusion in patients with ST-elevation Myocardial infarction by use of helicopter
por: Knudsen, Lars, et al.
Publicado: (2012)

Glucose Variability: Where It Is Important and How to Measure It
por: DeVries, J. Hans
Publicado: (2013)

Two case reports of transcatheter valve-in-valve implantation of Sapien 3 and MyVal in degenerated biological tricuspid prosthesis valves
por: Jensen, Rebekka Vibjerg, et al.
Publicado: (2022)

Staged re-evaluation of non-culprit lesions in ST segment elevation myocardial infarction: a retrospective study
por: Thim, Troels, et al.
Publicado: (2016)

Distance to invasive heart centre, performance of acute coronary angiography, and angioplasty and associated outcome in out-of-hospital cardiac arrest: a nationwide study
por: Tranberg, Tinne, et al.
Publicado: (2017)

Counterpoint: Clinical Islet Transplantation: Not Ready for Prime Time
por: Khan, Mahfuzul H., et al.
Publicado: (2009)

Point: Steady Progress and Current Challenges in Clinical Islet Transplantation
por: Mineo, Davide, et al.
Publicado: (2009)

A Critical Evaluation of Glycated Protein Parameters in Advanced Nephropathy: A Matter of Life or Death: A1C remains the gold standard outcome predictor in diabetic dialysis patients
por: Kalantar-Zadeh, Kamyar
Publicado: (2012)

A Critical Evaluation of Glycated Protein Parameters in Advanced Nephropathy: A Matter of Life or Death: Time to dispense with the hemoglobin A1C in end-stage kidney disease
por: Freedman, Barry I.
Publicado: (2012)

Response to commentary “Zinc is decreased in prostate cancer: an established relationship of prostate cancer!”
por: Banas, Agnieszka Maria, et al.
Publicado: (2010)

Point: Postprandial Glucose Levels Are a Clinically Important Treatment Target
por: Ceriello, Antonio
Publicado: (2010)

Counterpoint: Postprandial Glucose Levels Are Not a Clinically Important Treatment Target
por: Davidson, Mayer B.
Publicado: (2010)

Point: Intensive Glycemic Control and Mortality in ACCORD—A Chance Finding?
por: Lachin, John M.
Publicado: (2010)

Counterpoint: Intensive Glucose Control and Mortality in ACCORD—Still Looking for Clues
por: Riddle, Matthew C.
Publicado: (2010)

Mitochondrial Deficiency Is Associated With Insulin Resistance
por: Goodpaster, Bret H.
Publicado: (2013)

“Deficiency” of Mitochondria in Muscle Does Not Cause Insulin Resistance
por: Holloszy, John O.
Publicado: (2013)

Glucose Variability
por: Service, F. John
Publicado: (2013)

Insulin Analogs—Is There a Compelling Case to Use Them? No!
por: Davidson, Mayer B.
Publicado: (2014)

Validity of Meta-analysis in Diabetes: Meta-analysis Is an Indispensable Tool in Evidence Synthesis
por: Golden, Sherita Hill, et al.
Publicado: (2013)

Validity of Meta-analysis in Diabetes: We Need to Be Aware of Its Limitations
por: Home, Philip D.
Publicado: (2013)

Self-Monitoring of Blood Glucose in Noninsulin-Using Type 2 Diabetic Patients: It is time to face the evidence
por: Malanda, Uriëll L., et al.
Publicado: (2013)

Self-Monitoring of Blood Glucose in Noninsulin-Using Type 2 Diabetic Patients: Right answer, but wrong question: self-monitoring of blood glucose can be clinically valuable for noninsulin users
por: Polonsky, William H., et al.
Publicado: (2013)

A Critical Analysis of the Clinical Use of Incretin-Based Therapies: The benefits by far outweigh the potential risks
por: Nauck, Michael A.
Publicado: (2013)

Is Incretin-Based Therapy Ready for the Care of Hospitalized Patients With Type 2 Diabetes?: Insulin therapy has proven itself and is considered the mainstay of treatment
por: Umpierrez, Guillermo E., et al.
Publicado: (2013)

Is Incretin-Based Therapy Ready for the Care of Hospitalized Patients With Type 2 Diabetes?: The time has come for GLP-1 receptor agonists!
por: Schwartz, Stanley, et al.
Publicado: (2013)

A Critical Analysis of the Clinical Use of Incretin-Based Therapies : Are the GLP-1 therapies safe?
por: Butler, Peter C., et al.
Publicado: (2013)

Advanced Imaging Tools Rather Than Hemodynamics Should Be the Primary Approach for Diagnosing, Following, and Managing Pulmonary Arterial Hypertension
por: Gerges, Mario, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_t6fmqdf8drifslo96g7prij0mc